Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ERNA
PMCB
Add up to 3 more stocks
ERNA
Ernexa Therapeutics Inc.
-16.30%
$2.26-0.44Delayed quote: Oct 6, 2026, 2:15 PM EDT
Market Cap
$3.69M
52W Range
$2.70 - $71.50
PMCB
PharmaCyte Biotech, Inc.
+12.36%
$0.44+0.05Delayed quote: Oct 6, 2026, 1:58 PM EDT
Market Cap
$4.71M
52W Range
$0.33 - $1.51
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.15 | 0.17 |
| P/S Ratio | N/A | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% |
| ROE | -383.0% | -54.1% |
| ROA | -194.1% | -44.0% |
| ROIC | -346.9% | -19.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.01 | 40.30 |
| Quick Ratio | 2.01 | 40.30 |
| Debt/Equity | 0.11 | 0.00 |
| Interest Coverage | -345.15 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.